Europe Acute Lung Injury Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis By Therapy (Mechanical Ventilation, Fluid Management, Pharmacotherapy, and Adjunctive Procedures) and End User (Hospitals, Ambulatory Surgery Centers, and Others)

No. of Pages: 102    |    Report Code: TIPRE00025719    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Acute Lung Injury Market

TABLE OF CONTENTS

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Europe Acute Lung Injury Market – By Therapy

1.3.2        Europe Acute Lung Injury Market – By End User

1.3.3        Europe Acute Lung Injury Market– By Country

2.           Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Europe Acute Lung Injury Market– Market Landscape

4.1         Overview

4.2         Europe PEST Analysis

4.3         Experts Opinion

5.           Europe Acute Lung Injury Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Growing Prevalence of Respiratory Diseases

5.1.2        Increasing Geriatric Population

5.2         Market Restraints

5.2.1        Overpriced Therapies

5.3         Market Opportunities

5.3.1        Surging Technological Advancements by Market Players

5.4         Future Trends

5.4.1        Escalating Pipeline Drugs

5.5         Impact Analysis

6.           Acute Lung Injury Market– Europe Analysis

6.1         Europe Acute Lung Injury Market Revenue Forecast and Analysis

7.           Europe Acute Lung Injury Market Analysis – By Therapy

7.1         Overview

7.2         Europe Acute Lung Injury Market Revenue Share, by Therapy (2021 and 2028)

7.3         Mechanical Ventilation

7.3.1        Overview

7.3.2        Mechanical Ventilation: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Fluid Management

7.4.1        Overview

7.4.2        Fluid Management: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

7.5         Pharmacotherapy

7.5.1        Overview

7.5.2        Pharmacotherapy: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

7.6         Adjunctive Procedures

7.6.1        Overview

7.6.2        Adjunctive Procedures: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

8.           Europe Acute Lung Injury Market Analysis – By End User

8.1         Overview

8.2         Europe Acute Lung Injury Market Revenue Share, by End User (2021 and 2028)

8.3         Hospitals

8.3.1        Overview

8.3.2        Hospitals: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Ambulatory Surgery Centers

8.4.1        Overview

8.4.2        Ambulatory Surgery Centers: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

8.5         Others

8.5.1        Overview

8.5.2        Others: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

9.           Europe Acute Lung Injury Market – Country Analysis

9.1         Europe: Acute Lung Injury Market

9.1.1        Overview

9.1.2        Europe: Acute Lung Injury Market, by Country, 2021 & 2028(%)

9.1.2.1          Germany: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.1.1          Germany: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.1.2          Germany: Acute Lung Injury Market, by Therapy, 2019–2028 (USD Million)

9.1.2.1.3          Germany: Acute Lung Injury Market, by End User, 2019–2028 (USD Million)

9.1.2.2          France: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.2.1          France: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.2.2          France: Acute Lung Injury Market, by Therapy, 2019–2028 (USD Million)

9.1.2.2.3          France: Acute Lung Injury Market, by End User, 2019–2028 (USD Million)

9.1.2.3          UK: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.3.1          UK: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.3.2          UK: Acute Lung Injury Market, by Therapy, 2019–2028 (USD Million)

9.1.2.3.3          UK: Acute Lung Injury Market, by End User, 2019–2028 (USD Million)

9.1.2.4          Italy: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.4.1          Italy: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.4.2          Italy: Acute Lung Injury Market, by Therapy, 2019–2028 (USD Million)

9.1.2.4.3          Italy: Acute Lung Injury Market, by End User, 2019–2028 (USD Million)

9.1.2.5          Spain: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.5.1          Spain: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.5.2          Spain: Acute Lung Injury Market, by Therapy, 2019–2028 (USD Million)

9.1.2.5.3          Spain: Acute Lung Injury Market, by End User, 2019–2028 (USD Million)

9.1.2.6          Rest of Europe: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.6.1          Rest of Europe: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.6.2          Rest of Europe: Acute Lung Injury Market, by Therapy, 2019–2028 (USD Million)

9.1.2.6.3          Rest of Europe: Acute Lung Injury Market, by End User, 2019–2028 (USD Million)

10.        Impact Of COVID-19 Pandemic on Europe Acute Lung Injury Market

10.1      Europe: Impact Assessment of COVID-19 Pandemic

11.        Industry Landscape

11.1      Overview

11.2      Organic Developments

11.2.1     Overview

11.3      Inorganic Developments

11.3.1     Overview

12.        Company Profiles

12.1      GlaxoSmithKline Plc

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Stemedica Cell Technologies, Inc

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Histocell

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      APEPTICO Forschung und Entwicklung GmbH

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Windtree Therapeutics, Inc.

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Apeiron Biologics AG

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

LIST OF TABLES

Table 1.             Europe Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

Table 2.             Germany: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

Table 3.             Germany: Acute Lung Injury Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 4.             France: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

Table 5.             France: Acute Lung Injury Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 6.             UK: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

Table 7.             UK: Acute Lung Injury Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 8.             Italy: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

Table 9.             Italy: Acute Lung Injury Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 10.          Spain: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

Table 11.          Spain: Acute Lung Injury Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 12.          Rest of Europe: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

Table 13.          Rest of Europe: Acute Lung Injury Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 14.          Organic Developments Done by Companies

Table 15.          Inorganic Developments Done by Companies

Table 16.          Glossary of Terms

LIST OF FIGURES

Figure 1.           Europe Acute Lung Injury Market Segmentation

Figure 2.           Europe Acute Lung Injury Market Segmentation, By Country

Figure 3.           Europe Acute Lung Injury Market Overview

Figure 4.           Mechanical Ventilation Segment Held the Largest Share of the Market in 2021

Figure 5.           The UK to Show Significant Growth During Forecast Period

Figure 6.           Europe and PEST Analysis

Figure 7.           Europe Acute Lung Injury Market Impact Analysis of Driver and Restraints

Figure 8.           Europe Acute Lung Injury Market– Revenue Forecast and Analysis

Figure 9.           Europe Acute Lung Injury Market Revenue Share, by Therapy (2021 and 2028)

Figure 10.        Europe Mechanical Ventilation: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11.        Europe Fluid Management: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Europe Pharmacotherapy: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Europe Adjunctive Procedures: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Europe Acute Lung Injury Market Revenue Share, by End User (2021 and 2028)

Figure 15.        Europe Hospitals: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Europe Ambulatory Surgery Centers: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Europe Others: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Europe: Acute Lung Injury Market, by Key Country – Revenue (2021) (USD Million)

Figure 19.        Europe: Acute Lung Injury Market, by Country, 2021 & 2028 (%)

Figure 20.        Germany: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

Figure 21.        France: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

Figure 22.        UK: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

Figure 23.        Italy: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

Figure 24.        Spain: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

Figure 25.        Rest of Europe: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

Figure 26.        Impact of COVID-19 Pandemic in European Country Markets

The List of Companies - Europe Acute Lung Injury Market

  1. Apeiron Biologics AG
  2. APEPTICO Forschung und Entwicklung GmbH
  3. GlaxoSmithKline Plc
  4. Histocell
  5. Stemedica Cell Technologies, Inc
  6. Windtree Therapeutics, Inc.